Ralph Schiess

Amministratore Delegato presso ONCONETIX, INC.

Patrimonio netto: 45 048 $ in data 30/06/2024

46 anni

Health Technology

Consumer Services

Posizioni attive di Ralph Schiess

Società	Posizione	Inizio	Fine
ONCONETIX, INC.	Amministratore Delegato	12/01/2024	-
ONCONETIX, INC.	Direttore Tecnico/Scientifico/R&S	15/12/2023	-
ProteoMediX AG ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland.	Amministratore Delegato	01/01/2010	-
	Fondatore	01/01/2010	-
	Direttore/Membro del Consiglio	01/01/2010	01/01/2020
	Direttore Tecnico/Scientifico/R&S	01/01/2020	01/05/2023

University of Zurich	Graduate Degree
Swiss Federal Institute of Technology	Doctorate Degree

Distribuzione geografica

Svizzera	4
Stati Uniti	2

Posizioni

Settori

Health Technology	3
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
ONCONETIX, INC.	Health Technology

Aziende private	1
ProteoMediX AG ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland.	Health Technology

Aziende private

Health Technology